Cargando…
T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2
BACKGROUND: Tardive dyskinesia (TD) is a motor side effect that may arise after long-term treatment of antipsychotic drugs. Its etiology is not well understood, but a number of risk factors have been associated with TD. TD occurrence appears to be familial, thus suggesting a genetic component. We pr...
Autores principales: | Zai, Clement, Tiwari, Arun, Mueller, Daniel, Voineskos, Aristotle, Potkin, Steven G, Lieberman, Jeffrey, Meltzer, Herbert, Remington, Gary, Kennedy, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888487/ http://dx.doi.org/10.1093/schbul/sby016.283 |
Ejemplares similares
-
The effects of valbenazine on tardive dyskinesia in older and younger patients
por: Sajatovic, Martha, et al.
Publicado: (2019) -
A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
por: Patel, Rikinkumar S., et al.
Publicado: (2019) -
Investigation of the HSPG2 Gene in Tardive Dyskinesia – New Data and Meta-Analysis
por: Zai, Clement C., et al.
Publicado: (2018) -
Successful Treatment of Severe Tardive Dyskinesia with Valbenazine, Including a Patient’s Perspective
por: Josiassen, Richard C., et al.
Publicado: (2017) -
Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
por: Yee, Maria Ruiza, et al.
Publicado: (2020)